Product Images Abstral

This is a dosage titration process for ABSTRAL, a medication used for breakthrough pain. The initial dose is 100 meg and subsequent doses are adjusted according to a table provided. Adequate pain relief should be achieved within 30 minutes, and subsequent doses should be separated by at least 2 hours. The table provides dosing instructions for various doses from 200 meg to 800 meg.*

The text is not-available as it consists of random characters and unidentifiable symbols.*

ABSTRAL®G is a medication that comes in the form of sublingual tablets containing fentanyl. It is not recommended to swallow the tablet whole and it can only be administered sublingually. The text also includes a reference number and contact information for questions. However, due to errors and non-English characters, the text is not very clear.*

ABSTRAL is a medication in the form of sublingual tablets containing fentanyl, used for management of breakthrough cancer pain in adults who are regularly taking opioids. The text also includes some unreadable characters and symbols.*

This is for a medication called ABSTRAL, which is a fentanyl sublingual tablet used for pain management. The text includes dosage and safety information, as well as contact details for questions or concerns.*

ABSTRAL is a brand name of sublingual fentanyl tablets indicated for the management of breakthrough cancer pain in opioid-tolerant patients. The text also includes product information such as dosage, strength, and administration instructions.*

ABSTRAL® is a sublingual tablet containing fentanyl, produced by Novartis. It is equivalent to ERTORRYSR, and each tablet contains 22 subtngos Tavts. The tablet should not be chewed or swallowed whole. The rest of the text is not available.*